Ingevity Corporation: stock overview

NGVTNYSEBasic materials · Chemicals & Allied Products

Price

$61.72

November 13, 2026Market cap $2.2B

DCF calculator

What Ploutos Investor adds for Ingevity

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 12 fiscal years, from 2014
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.

In short

Ingevity had revenue of $1.1B over the last 12 months and net income of $60M, a net margin of 5.3%. Revenue fell by 0.8% a year on average over the last 5 years. At $61.72 the shares trade at a P/E of 36.4. It has net debt of $1.1B. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$2.2B
35.29M shares
P/E
36.4
Revenue, 12 months
$1.1B
-0.8% a year over 5 years
Net margin
5.3%
2025: -14.3%, above 37% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

-2.0% a year over 2 years

  • 202510-K
    Revenue$1.2B
  • 202410-K
    Revenue$1.2B
  • 202310-K
    Revenue$1.2B

Fiscal years in figures

NGVT's revenue, profit, cash flow and dividend with each year-end price, from 2014 to 2022, 9 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $1.7B
$2.2B
Enterprise value 
$3.2B
P/E 
36.4
EV / EBIT 
72.8
EV / Revenue 
2.9
P/B 3-year median: 7.6
34.6
FCF yield 3-year median: 5.6%
5.6%
Earnings yield 3-year median: -7.8%
2.8%

Profitability

Gross margin 
42.1%
Operating margin 
3.9%
Net margin 3-year median: -14.3%
5.3%
ROIC 
2.8%
ROIC, 5-year average 
19.5%
ROE 
94.4%

Growth

Revenue, yearly change 
-2.7%
EPS, yearly change 
–
FCF, yearly change 
+436.3%
Revenue, average a year 
-0.8%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$85M
Total debt 
$1.2B
Of which operating leases 
$33M
Net debt 
$1.1B
Net debt / EBITDA 
7.0x
Interest cover 
0.6x
Current ratio 
1.48

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
2.58%
Total returned 
2.58%
Shares, yearly change 
-2.9%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 28).

Gross margin

39.5%

Above 48% of the 141 companies in its industry, and 55% of all.

Operating margin

35.9%

Above 95% of the 285 companies in its industry, and 95% of all.

Net margin

-14.3%

Above 37% of the 302 companies in its industry, and 16% of all.

ROE

-562.6%

Above 2% of the 267 companies in its industry, and 0% of all.

ROA

-10.1%

Above 35% of the 313 companies in its industry, and 14% of all.

Revenue growth

-2.7%

Above 26% of the 292 companies in its industry, and 21% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Ingevity Corp
CIK
1653477
Exchange
NYSE
Industry (SIC)
2800 · Chemicals & Allied Products
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
35.29M

Other companies: Basic materials

The largest companies of the same sector, each with its own page.

The Basic materials sectorAll companies

The full analysis

What do Ingevity's filings show?

These are Ingevity's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NGVT

Didn't find what you were looking for?

Ask us
What is NGVT's market cap?

Ingevity Corporation's market cap is $2.2B, at a price of $61.72 on November 13, 2026 and 35.29M shares.

What is NGVT's P/E?

NGVT's P/E is 36.4, on earnings per share of $1.73 over the last 12 months.

How much revenue does NGVT have?

Ingevity had revenue of $1.1B over the last 12 months. Over the last 5 years it changed by -0.8% a year on average.

Does NGVT pay a dividend?

No. Ingevity paid no regular dividend over the last 12 months.

Where do the figures come from?

From Ingevity Corporation's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.